Studies using computer modelling of glucose and insulin kinetics after intravenous glucose challenge have demonstrated that patients with type 2 diabetes have significantly lower values of both insulin-independent glucose removal rate (SG) and insulin sensitivity (SI) than those who remain normoglycaemic (Table 1) [2, 12–14]. This evidence concerns the gene INS and type 2 diabetes mellitus.